NewAmsterdam Pharma
VerifiedWork at NewAmsterdam Pharma.
NewAmsterdam Pharma is a late-stage biopharmaceutical company developing oral therapies for cardiometabolic diseases. Its lead candidate, obicetrapib, is a CETP inhibitor in Phase 3 development to lower LDL cholesterol in patients with cardiovascular disease...
Healthcare
Open roles
2
Founded
2019
Type
Public
Team size
201–500
Headquarters
Naarden, North Holland, Netherlands
Website
newamsterdampharma.com
View on LinkedIn →
Open roles at NewAmsterdam Pharma
2 open rolesSubscribe to Career Resources.
Get the latest career advice, industry insights, and job opportunities delivered straight to your inbox.
